Cargando…

Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates

Bisphosphonates have a long history in the treatment of osteoporosis and bone-related disease. This review focuses on the use of a specific nonaminobisphosphonate, clodronate, which appears to be much better tolerated than other bisphosphonates and free of high-risk contraindications. Specifically,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muratore, Maurizio, Quarta, Eugenio, Grimaldi, Antonella, Calcagnile, Fabio, Quarta, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3210073/ https://www.ncbi.nlm.nih.gov/pubmed/22087064 http://dx.doi.org/10.2147/DDDT.S12139

Ejemplares similares

Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells
por: Journe, F, et al.
Publicado: (2004)

The stunning clodronate
por: Mass, Elvira
Publicado: (2023)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Treatment of malignant hypercalcaemia with clodronate.
por: Percival, R. C., et al.
Publicado: (1985)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Indirect osteoblast differentiation by liposomal clodronate
por: Okada, Emi, et al.
Publicado: (2017)

Clodronate Treatment Prevents Vaginal Hypersensitivity in a Mouse Model of Vestibulodynia
por: Castro, Joel, et al.
Publicado: (2022)

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
por: Bauss, Frieder, et al.
Publicado: (2006)

Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
por: Figueiredo, Marília A., et al.
Publicado: (2020)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Bock, Oliver, et al.
Publicado: (2008)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)

Prevention of Type 1 Diabetes in Children: A Worthy Challenge?
por: Ingrosso, Diletta Maria Francesca, et al.
Publicado: (2023)

Dating old hollow trees by applying a multistep tree-ring and radiocarbon procedure to trunk and exposed roots
por: Piovesan, Gianluca, et al.
Publicado: (2018)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)

Long-term use of bisphosphonates in osteoporosis
por: Alwahhabi, Basmah K., et al.
Publicado: (2017)

Meta-analysis of clodronate and breast cancer survival
por: Ha, T C, et al.
Publicado: (2007)

Clodronate as a Therapeutic Strategy against Osteoarthritis
por: Valenti, Maria Teresa, et al.
Publicado: (2017)

The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis
por: Moretti, Antimo, et al.
Publicado: (2021)

Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
por: Cotté, François-Emery, et al.
Publicado: (2011)

Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
por: Miller, P. D., et al.
Publicado: (2016)

Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
por: Park, Ji-Heh, et al.
Publicado: (2017)

Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
por: Fatoye, F, et al.
Publicado: (2019)

Clinicians’ views of prescribing oral and intravenous bisphosphonates for osteoporosis: a qualitative study
por: Bishop, Simon, et al.
Publicado: (2023)

Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication
por: Balkhi, Bander, et al.
Publicado: (2018)

Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations
por: Sunyecz, John
Publicado: (2008)

The dynamics of a Mediterranean coralligenous sponge assemblage at decennial and millennial temporal scales
por: Bertolino, Marco, et al.
Publicado: (2017)

Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
por: Yuan, Chuanjian, et al.
Publicado: (2023)

Potential Adverse Effect of Nonsteroidal Anti‐Inflammatory Drugs (NSAIDs) on Bisphosphonate Efficacy: An Exploratory Post Hoc Analysis From a Randomized Controlled Trial of Clodronate
por: Zheng, Zhangan, et al.
Publicado: (2022)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Physicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates
por: Gu, Tao, et al.
Publicado: (2016)

ERT, HRT, Raloxifine, Calcitonin, or Bisphosphonates for Osteoporosis
por: Curtiss, Frederic R.
Publicado: (2003)

Effect of Lumbar Spinal Stenosis on Treatment of Osteoporosis: Comparison of Three Oral Bisphosphonate Therapies
por: Park, Hyung-Youl, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aolek54sb8metn7ak7mjsrhqd6